| Primary |
| Urinary Tract Infection |
22.2% |
| Cellulitis |
11.1% |
| Condition Aggravated |
11.1% |
| Cystic Fibrosis |
11.1% |
| Cystic Fibrosis Lung |
11.1% |
| Drug Resistance |
11.1% |
| Lung Infection Pseudomonal |
11.1% |
| Pancreatitis |
11.1% |
|
| Renal Failure Acute |
44.4% |
| Nephropathy Toxic |
11.1% |
| Paraesthesia Oral |
11.1% |
| Tachypnoea |
11.1% |
| Tracheal Haemorrhage |
11.1% |
| Tubulointerstitial Nephritis |
11.1% |
|
| Secondary |
| Pseudomonas Infection |
24.1% |
| Mycobacterium Abscessus Infection |
19.5% |
| Product Used For Unknown Indication |
10.2% |
| Acinetobacter Infection |
5.6% |
| Drug Use For Unknown Indication |
5.1% |
| Klebsiella Infection |
4.5% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Staphylococcal Bacteraemia |
3.6% |
| Antibiotic Prophylaxis |
3.4% |
| Autoimmune Hepatitis |
3.4% |
| Antibiotic Therapy |
3.2% |
| Pneumonia |
2.4% |
| Acute Myeloid Leukaemia |
2.3% |
| Lymphocytic Leukaemia |
1.7% |
| Sepsis |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Infection |
1.1% |
| Lung Disorder |
1.1% |
| Septic Shock |
1.1% |
| Clostridial Infection |
0.8% |
|
| Tachycardia |
14.3% |
| Renal Tubular Necrosis |
13.0% |
| Renal Failure Acute |
11.7% |
| Acinetobacter Infection |
6.5% |
| Dehydration |
5.2% |
| Drug Ineffective |
5.2% |
| Septic Shock |
5.2% |
| Pigmentation Disorder |
3.9% |
| Skin Exfoliation |
3.9% |
| Thrombocytopenia |
3.9% |
| Weight Decreased |
3.9% |
| C-reactive Protein Increased |
2.6% |
| Clostridium Difficile Colitis |
2.6% |
| Condition Aggravated |
2.6% |
| Death |
2.6% |
| Multi-organ Failure |
2.6% |
| Multiple-drug Resistance |
2.6% |
| Necrotising Ulcerative Gingivostomatitis |
2.6% |
| Staphylococcal Infection |
2.6% |
| Status Epilepticus |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.2% |
| Product Used For Unknown Indication |
20.7% |
| Cystic Fibrosis |
16.2% |
| Acute Myeloid Leukaemia |
7.0% |
| Prophylaxis |
5.9% |
| Pseudomonas Infection |
3.5% |
| Sepsis |
3.0% |
| Heart And Lung Transplant |
1.9% |
| Cystic Fibrosis Lung |
1.7% |
| Respiratory Tract Infection |
1.6% |
| Bacteraemia |
1.4% |
| Coronary Artery Disease |
1.4% |
| Therapeutic Procedure |
1.4% |
| Acinetobacter Bacteraemia |
1.3% |
| Antibiotic Therapy |
1.3% |
| Lung Transplant |
1.3% |
| B-cell Lymphoma |
1.1% |
| Acute Lymphocytic Leukaemia |
1.0% |
| Medical Diet |
1.0% |
| Pyrexia |
1.0% |
|
| Renal Failure Acute |
13.6% |
| Pneumonia |
12.5% |
| Drug Ineffective |
9.1% |
| Sepsis |
8.0% |
| Death |
6.8% |
| Thrombocytopenia |
5.7% |
| Troponin I Increased |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Renal Failure |
4.5% |
| Ageusia |
3.4% |
| Lung Infection |
3.4% |
| Renal Tubular Necrosis |
3.4% |
| Cerebrovascular Accident |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Dyspnoea |
2.3% |
| Feeling Hot |
2.3% |
| Haemoptysis |
2.3% |
| Hypersensitivity |
2.3% |
| Liver Disorder |
2.3% |
| Nausea |
2.3% |
|
